| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2014/920467 |
| P8608 | Fatcat ID | release_pw6g7tbp7jdm5flgwxjejtde74 |
| P932 | PMC publication ID | 3977461 |
| P698 | PubMed publication ID | 24778868 |
| P5875 | ResearchGate publication ID | 261957530 |
| P50 | author | Megan E B Clowse | Q89851486 |
| P2093 | author name string | Amelie M Schramm | |
| P2860 | cites work | Practice Bulletin No. 132: Antiphospholipid syndrome. | Q51295029 |
| Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. | Q51865183 | ||
| Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease. | Q53170451 | ||
| Systemic lupus erythematosus. | Q53495545 | ||
| Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. | Q53497854 | ||
| Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. | Q53538854 | ||
| First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia. | Q54439388 | ||
| Pregnancy Outcomes in Systemic Lupus Erythematosus with and without Previous Nephritis | Q59552743 | ||
| The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies | Q69518311 | ||
| Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy | Q72761536 | ||
| A meta-analysis of low-dose aspirin for prevention of preeclampsia | Q84305671 | ||
| Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: a meta-analysis with individual patient data | Q30607061 | ||
| Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus | Q33366857 | ||
| A national study of the complications of lupus in pregnancy | Q33379485 | ||
| Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array | Q33761815 | ||
| Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies | Q33930498 | ||
| Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome | Q34274883 | ||
| Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk | Q34409903 | ||
| Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. | Q34765324 | ||
| Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review | Q35136184 | ||
| New insights into pregnancy-related complications in systemic lupus erythematosus | Q35216314 | ||
| Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases | Q35953379 | ||
| Endothelial progenitor cells: a new player in lupus? | Q36084953 | ||
| Lupus activity in pregnancy | Q36820979 | ||
| The glomerular injury of preeclampsia | Q36883342 | ||
| A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma | Q36984261 | ||
| Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model | Q37311066 | ||
| The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. | Q37367745 | ||
| Mechanisms of antiphospholipid antibody-associated pregnancy complications | Q37576620 | ||
| Review: The angiogenic and vasodilatory utero-placental network | Q37836045 | ||
| Is heparin a placental anticoagulant in high-risk pregnancies? | Q37922446 | ||
| Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new. | Q38023853 | ||
| Fetal and neonatal effects of anticoagulants used in pregnancy: a review | Q38055192 | ||
| Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia | Q38070471 | ||
| Regulatory T cells in systemic lupus erythematosus and pregnancy | Q38080562 | ||
| Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. | Q44114229 | ||
| Antiphospholipid antibodies prolong the activation of endothelial cells induced by necrotic trophoblastic debris: implications for the pathogenesis of preeclampsia. | Q46176567 | ||
| Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
| Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis | Q22306400 | ||
| Antiplatelet agents for preventing pre-eclampsia and its complications | Q24245285 | ||
| Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials | Q26828468 | ||
| Is inflammation the cause of pre-eclampsia? | Q27007059 | ||
| Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study | Q28218530 | ||
| A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. | Q30433214 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | aspirin | Q18216 |
| pre-eclampsia | Q61335 | ||
| maternal health | Q6786626 | ||
| P304 | page(s) | 920467 | |
| P577 | publication date | 2014-03-20 | |
| P1433 | published in | Autoimmune Diseases | Q26842451 |
| P1476 | title | Aspirin for prevention of preeclampsia in lupus pregnancy | |
| P478 | volume | 2014 |
| Q38618636 | Adjudin--A Male Contraceptive with Other Biological Activities |
| Q36421501 | Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study |
| Q36523163 | Differences in Liver Injury and Trophoblastic Mitochondrial Damage in Different Preeclampsia-like Mouse Models |
| Q37697905 | Evaluation the effect of low-dose aspirin on endothelial dysfunction in preeclamptic patients |
| Q37262640 | Immunohistochemical Expression of Myeloperoxidase in Placental Samples of Systematic Lupus Erythematosus Pregnancies |
| Q35956397 | Lack of Thromboxane Synthase Prevents Hypertension and Fetal Growth Restriction after High Salt Treatment during Pregnancy |
| Q55034901 | Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis. |
| Q37136212 | Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q58693234 | Postpartum nephrotic syndrome related to new onset of systemic lupus erythematosus: A case report |
| Q55257140 | Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study. |
| Q33559194 | Pregnancy: An Underutilized Window of Opportunity to Improve Long-term Maternal and Infant Health-An Appeal for Continuous Family Care and Interdisciplinary Communication |
| Q26741149 | Systemic lupus erythematosus: strategies to improve pregnancy outcomes |
| Q28072610 | The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus |
| Q36166677 | The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study. |
Search more.